<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00118365</url>
  </required_header>
  <id_info>
    <org_study_id>NCI-2009-00880</org_study_id>
    <secondary_id>UCI 97-05</secondary_id>
    <secondary_id>R01CA088078</secondary_id>
    <nct_id>NCT00118365</nct_id>
    <nct_alias>NCT00005882</nct_alias>
  </id_info>
  <brief_title>Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps</brief_title>
  <official_title>A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Combination of DFMO and Sulindac to Decrease the Rate of Recurrence of Adenomatous Polyps in the Colon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      This randomized phase III trial is studying eflornithine and sulindac to see how well they
      work compared to a placebo in preventing colorectal cancer in patients with colon polyps.
      Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming
      back. The use of eflornithine and sulindac may prevent colorectal cancer. It is not yet known
      whether eflornithine and sulindac are more effective than a placebo in preventing colorectal
      cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      I. Compare the rate of new adenomatous polyp formation in patients with a history of
      adenomatous polyps of the colon treated with eflornithine and sulindac vs placebo.

      II. Correlate the effects of eflornithine and sulindac on polyamine and prostaglandin content
      in the flat mucosa with the rate of new adenoma formation in these patients.

      III. Compare the rate of side effects in patients treated with these regimens.

      OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients
      are stratified according to participating center and aspirin use (yes vs no).

      Patients receive oral double placebo once daily for 4 weeks. Patients who are more than 70%
      compliant by pill measurement or self reporting are randomized to 1 of 2 treatment arms.

      Arm I: Patients receive oral double placebo once daily.

      Arm II: Patients receive oral eflornithine (DFMO) and oral sulindac once daily.

      In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or
      the development of an invasive malignancy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 1998</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Detection of any adenoma at the end of the study. This analysis is based on the participants who had the end-of-study colonscopy procedure done.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Baseline Prostaglandin E2 (PGE2) and Treatment</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>This analysis is based on the participants who had the end-of-study colonscopy procedure done and their baseline PGE2 values are available. The low PGE2 is defined as the values that are below the median PGE2 value in the analysis cohort. The high PGE2 is defined as the values that are above the median PGE2 value in the analysis cohort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Baseline Putrescine and Treatment</measure>
    <time_frame>Up 36 months</time_frame>
    <description>The low is defined as the values that are below the median putrescine level in the analysis cohort. The high is defined as the values that are above the median putrescine level in the analysis cohort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Baseline Spermidine-to-spermine Ratio and Treatment</measure>
    <time_frame>Up 36 months</time_frame>
    <description>The low is defined as the ratios that are below the median spermidine-to-spermine ratio in the analysis cohort. The high is defined as the ratios that are above the median spermidine-to-spermine ratio in the analysis cohort.
In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset.
The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Prostaglandin E2 (PGE2) Response and Treatment</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>PGE2 Responder = PGE2 values at 36-month are decreased by &gt;=30% in PGE2 values from baseline PGE2 nonresponder = PGE2 values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Putrescine Response and Treatment</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Putrescine responder = Putrescine values at 36-month are decreased by &gt;=30% from baseline Putrescine nonresponder = Putrescine values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of Any Adenoma at the End of the Study Stratified by Spermidine-to-spermine Ratio Response and Treatment</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Spermidine-to-spermine ratio responder = ratios at 36-month are decreased by &gt;=30% from baseline Spermidine-to-spermine ratio nonresponder = ratios at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events With a Grade of 3 and Above</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>Participants reported at least 1 adverse event with a grade of 3 and above, regardless if the event is defined as serious per protocol or other.
Per protocol, not all grade 3 events are considered as serious events.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Putrescine by ODC Genotype</measure>
    <time_frame>Baseline</time_frame>
    <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Spermidine by ODC Genotype</measure>
    <time_frame>Baseline</time_frame>
    <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Spermine by ODC Genotype</measure>
    <time_frame>Baseline</time_frame>
    <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>At the End of the Study - Putrescine Response by ODC Genotype</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Putrescine responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) â‰¥ the threshold. Putrescine non-responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>At the End of the Study - Spermidine Response by ODC Genotype</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Spermidine responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) â‰¥ the threshold. Spermidine non-responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>At the End of the Study - Spermine Response by ODC Genotype</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Spermine responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) â‰¥ the threshold. Spermine non-responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Have Adenoma Recurrence in Each ODC1 Genotytpe by Treatment Group</measure>
    <time_frame>Up to 36 months</time_frame>
    <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma: Apoptosis</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Apoptosis expression was assessed using cytoplasmic staining. The definitions for the category level for the Apoptosis are: 1. focal (less than 10% cells that are positively stained); 2. less than 50% cells are positively stained; 3. more than 50% cells are positively stained.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma - Ki-67</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Estimated mean percent of cells staining postivie for the Ki-67 based on the GEE approach with adjustment for covariates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma: CEA</measure>
    <time_frame>At the end of the study</time_frame>
    <description>carcino-embryonic antigen (CEA) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma: Sialyl-TN (B72.3)</measure>
    <time_frame>At the end of the study</time_frame>
    <description>sialyl-Tn (B72.3) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma - p53</measure>
    <time_frame>At the end of the study</time_frame>
    <description>Estimated mean percent of cells staining postivie for p53 based on GEE approach with adjument for covariates.
Tumor protein p53, also known as p53, cellular tumor antigen p53, phosphoprotein p53, or tumor suppressor p53, is a protein that in humans is encoded by the TP53 gene.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Adenoma: Bcl-2</measure>
    <time_frame>At the end of the study, up to 3 years</time_frame>
    <description>bcl-2 is the anti-apoptotic protein BCL2</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">375</enrollment>
  <condition>Precancerous Condition</condition>
  <arm_group>
    <arm_group_label>Arm II (placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm I (eflornithine and sulindac)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Given orally</description>
    <arm_group_label>Arm II (placebo)</arm_group_label>
    <other_name>PLCB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>eflornithine</intervention_name>
    <description>Given orally</description>
    <arm_group_label>Arm I (eflornithine and sulindac)</arm_group_label>
    <other_name>2-difluoromethylornithine</other_name>
    <other_name>DFMO</other_name>
    <other_name>difluromethylornithine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sulindac</intervention_name>
    <description>Given orally</description>
    <arm_group_label>Arm I (eflornithine and sulindac)</arm_group_label>
    <other_name>Aflodac</other_name>
    <other_name>Algocetil</other_name>
    <other_name>Clinoril</other_name>
    <other_name>SULIN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm II (placebo)</arm_group_label>
    <arm_group_label>Arm I (eflornithine and sulindac)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Criteria:

          -  History of &gt;= 1 surgically resected adenomatous polyp of the colon measuring &gt;= 3 mm
             within the past 5 years

          -  Screening colonoscopy performed within the past 6 months

          -  All polyps must have been removed during colonoscopy, pathologically examined, and
             archived

          -  No prior surgical resection removing &gt; 40 cm of the colon

          -  No personal or family history of familial polyposis or hereditary non-polyposis colon
             cancer

          -  SWOG 0-1

          -  Bilirubin =&lt; 2.0 mg/dL

          -  AST and ALT =&lt; 2 times normal

          -  Creatinine =&lt; 1.5 mg/dL

          -  Urine protein =&lt;, urine casts 0-3, urine WBC and RBC count 0-5 cells by urinalysis

          -  No history of inflammatory bowel disease

          -  No gastric or duodenal ulcers within the past 12 months

          -  Gastric or duodenal ulcers that were adequately treated &gt; 24 months ago are allowed

          -  No symptomatic gastric or duodenal ulcers

          -  Not pregnant or nursing

          -  Negative pregnancy test

          -  Must have regional geographic stability over the next 36 months

          -  Pure tone audiometry evaluation normal

          -  Patients with &gt;= 20 dB of uncorrectable hearing loss (for age) of any 2 contiguous
             frequencies are not allowed

          -  No invasive malignancy within the past 5 years except adequately treated nonmelanoma
             skin cancer, level I (or Breslow &lt; 0.76 mm) cutaneous melanoma, Duke's A colon cancer,
             stage I cervical cancer, or stage 0 chronic lymphocytic leukemia

          -  No severe metabolic disorder

          -  No other significant acute or chronic disease that would preclude study participation

          -  No history of abnormal wound healing or repair

          -  No conditions that would confer risk of abnormal wound healing or repair

          -  No history of allergy to NSAIDs or eflornithine

          -  No concurrent chemotherapy

          -  No concurrent corticosteroids on a regular or predictable intermittent basis

          -  No concurrent radiotherapy

          -  Concurrent calcium supplements (=&lt; 1,000 mg/day) allowed

          -  Concurrent lipid-lowering drugs (i.e., high-dose statins) allowed

          -  No other concurrent nonsteroidal anti-inflammatory drugs (NSAIDs) on a regular or
             predictable intermittent basis

          -  Concurrent aspirin for cardiovascular prophylaxis (i.e., 81 mg/day) allowed

          -  No concurrent anticoagulants on a regular or predictable intermittent basis

          -  No concurrent treatment for gastric or duodenal ulcers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Meyskens</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California Medical Center At Irvine-Orange Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California Medical Center At Irvine-Orange Campus</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Australia</country>
  </removed_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2005</study_first_submitted>
  <study_first_submitted_qc>July 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2005</study_first_posted>
  <results_first_submitted>April 18, 2014</results_first_submitted>
  <results_first_submitted_qc>January 12, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 22, 2015</results_first_posted>
  <last_update_submitted>January 12, 2015</last_update_submitted>
  <last_update_submitted_qc>January 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Precancerous Conditions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulindac</mesh_term>
    <mesh_term>Eflornithine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Arm I (Eflornithine and Sulindac)</title>
          <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
        <group group_id="P2">
          <title>Arm II (Placebo)</title>
          <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="184"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="132"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Randomized participants</population>
      <group_list>
        <group group_id="B1">
          <title>Arm I (Eflornithine and Sulindac)</title>
          <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
        <group group_id="B2">
          <title>Arm II (Placebo)</title>
          <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="191"/>
            <count group_id="B2" value="184"/>
            <count group_id="B3" value="375"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60" spread="8.6"/>
                    <measurement group_id="B2" value="61" spread="8.4"/>
                    <measurement group_id="B3" value="60.5" spread="8.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="285"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Detection of Any Adenoma at the End of the Study</title>
        <description>Detection of any adenoma at the end of the study. This analysis is based on the participants who had the end-of-study colonscopy procedure done.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>This analysis is based on the participants who had the end-of-study colonscopy procedure done.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study</title>
          <description>Detection of any adenoma at the end of the study. This analysis is based on the participants who had the end-of-study colonscopy procedure done.</description>
          <population>This analysis is based on the participants who had the end-of-study colonscopy procedure done.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="138"/>
                <count group_id="O2" value="129"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121"/>
                    <measurement group_id="O2" value="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Prostaglandin E2 (PGE2) and Treatment</title>
        <description>This analysis is based on the participants who had the end-of-study colonscopy procedure done and their baseline PGE2 values are available. The low PGE2 is defined as the values that are below the median PGE2 value in the analysis cohort. The high PGE2 is defined as the values that are above the median PGE2 value in the analysis cohort.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>This analysis is based on the participants who had the end-of-study colonscopy procedure done and their baseline PGE2 values are available. The low PGE2 is defined as the values that are below the median PGE2 value in the analysis cohort. The high PGE2 is defined as the values that are above the median PGE2 value in the analysis cohort.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + Low PGE2 at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline PGE2 values is below the median</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + High PGE2 at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline PGE2 values is above the median</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Low PGE2 at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline PGE2 value is below median</description>
          </group>
          <group group_id="O4">
            <title>Placebo + High PGE2 at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline PGE2 value is above median</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Prostaglandin E2 (PGE2) and Treatment</title>
          <description>This analysis is based on the participants who had the end-of-study colonscopy procedure done and their baseline PGE2 values are available. The low PGE2 is defined as the values that are below the median PGE2 value in the analysis cohort. The high PGE2 is defined as the values that are above the median PGE2 value in the analysis cohort.</description>
          <population>This analysis is based on the participants who had the end-of-study colonscopy procedure done and their baseline PGE2 values are available. The low PGE2 is defined as the values that are below the median PGE2 value in the analysis cohort. The high PGE2 is defined as the values that are above the median PGE2 value in the analysis cohort.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="44"/>
                <count group_id="O3" value="42"/>
                <count group_id="O4" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="23"/>
                    <measurement group_id="O4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Putrescine and Treatment</title>
        <description>The low is defined as the values that are below the median putrescine level in the analysis cohort. The high is defined as the values that are above the median putrescine level in the analysis cohort.</description>
        <time_frame>Up 36 months</time_frame>
        <population>In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset. The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + Low Putrescine at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline Putrescine values is below the median</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + High Putrescine at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline Putrescine values is above the median</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Low Putrescine at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline Putrescine value is below median</description>
          </group>
          <group group_id="O4">
            <title>Placebo + High Putrescine at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline Putrescine value is above median</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Putrescine and Treatment</title>
          <description>The low is defined as the values that are below the median putrescine level in the analysis cohort. The high is defined as the values that are above the median putrescine level in the analysis cohort.</description>
          <population>In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset. The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="62"/>
                <count group_id="O4" value="67"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="56"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Spermidine-to-spermine Ratio and Treatment</title>
        <description>The low is defined as the ratios that are below the median spermidine-to-spermine ratio in the analysis cohort. The high is defined as the ratios that are above the median spermidine-to-spermine ratio in the analysis cohort.
In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset.
The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Up 36 months</time_frame>
        <population>In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset. The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + Low Spd:Spm at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline spermidine-to-spermine ratio is below the median</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + High Spd:Spm at Baseline</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
baseline spermidine-to-spermine ratio is above the median</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Low Spd:Spm at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline spermidine-to-spermine ratio is below median</description>
          </group>
          <group group_id="O4">
            <title>Placebo + High Spd:Spm at Baseline</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
baseline spermidine-to-spermine ratio is above median</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Baseline Spermidine-to-spermine Ratio and Treatment</title>
          <description>The low is defined as the ratios that are below the median spermidine-to-spermine ratio in the analysis cohort. The high is defined as the ratios that are above the median spermidine-to-spermine ratio in the analysis cohort.
In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset.
The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>In the finalized datasaet, the total number of adnoma detected in the placebo group is 55. The descrepancy in the total number of adnoma detected in placebo group between Outcome Measure 1 and this oucome is due to the revolution of the datatset. The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="60"/>
                    <measurement group_id="O3" value="37"/>
                    <measurement group_id="O4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Prostaglandin E2 (PGE2) Response and Treatment</title>
        <description>PGE2 Responder = PGE2 values at 36-month are decreased by &gt;=30% in PGE2 values from baseline PGE2 nonresponder = PGE2 values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + PGE2 Responders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
PGE2 Responder = PGE2 values at 36-month are decreased by &gt;=30% in PGE2 values from baseline</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + PGE2 Nonresponders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
PGE2 nonresponder = PGE2 values at 36-month are increased, or decreased by &lt; 30% from baseline</description>
          </group>
          <group group_id="O3">
            <title>Placebo + PGE2 Responders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
PGE2 Responder = PGE2 values at 36-month are decreased by &gt;=30% in PGE2 values from baseline</description>
          </group>
          <group group_id="O4">
            <title>Placebo + PGE2 Nonresponders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
PGE2 nonresponder = PGE2 values at 36-month are increased, or decreased by &lt; 30% from baseline</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Prostaglandin E2 (PGE2) Response and Treatment</title>
          <description>PGE2 Responder = PGE2 values at 36-month are decreased by &gt;=30% in PGE2 values from baseline PGE2 nonresponder = PGE2 values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="17"/>
                <count group_id="O4" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Putrescine Response and Treatment</title>
        <description>Putrescine responder = Putrescine values at 36-month are decreased by &gt;=30% from baseline Putrescine nonresponder = Putrescine values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + Putrescine Responders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
Putrescine responder = Putrescine values at 36-month are decreased by &gt;=30% from baseline</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + Putrescine Nonresponders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
Putrescine nonresponder = Putrescine values at 36-month are increased, or decreased by &lt; 30% from baseline</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Putrescine Responders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
Putrescine responder = Putrescine values at 36-month are decreased by &gt;=30% from baseline</description>
          </group>
          <group group_id="O4">
            <title>Placebo + Putrescine Nonresponders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
Putrescine nonresponder = Putrescine values at 36-month are increased, or decreased by &lt; 30% from baseline</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Putrescine Response and Treatment</title>
          <description>Putrescine responder = Putrescine values at 36-month are decreased by &gt;=30% from baseline Putrescine nonresponder = Putrescine values at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="53"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Detection of Any Adenoma at the End of the Study Stratified by Spermidine-to-spermine Ratio Response and Treatment</title>
        <description>Spermidine-to-spermine ratio responder = ratios at 36-month are decreased by &gt;=30% from baseline Spermidine-to-spermine ratio nonresponder = ratios at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>Eflornithine and Sulindac + Spd:Spm Responders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
Spd:Spm Responder = spermidine-to-spermine ratio at 36-month are decreased by &gt;=30% from baseline</description>
          </group>
          <group group_id="O2">
            <title>Eflornithine and Sulindac + Spd:Spm Nonresponders</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. The treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies
Spd:Spm nonresponder = spermidine-to-spermine ratio at 36-month increased, or decreased by &lt; 30% from baseline</description>
          </group>
          <group group_id="O3">
            <title>Placebo + Spd:Spm Responders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
SpSpd:Spm Responder = spermidine-to-spermine ratio at 36-month are decreased by &gt;=30% from baseline</description>
          </group>
          <group group_id="O4">
            <title>Placebo + Spd:Spm Nonresponders</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies
Spd:Spm nonresponder = spermidine-to-spermine ratio at 36-month increased, or decreased by &lt; 30% from baseline</description>
          </group>
        </group_list>
        <measure>
          <title>Detection of Any Adenoma at the End of the Study Stratified by Spermidine-to-spermine Ratio Response and Treatment</title>
          <description>Spermidine-to-spermine ratio responder = ratios at 36-month are decreased by &gt;=30% from baseline Spermidine-to-spermine ratio nonresponder = ratios at 36-month are increased, or decreased by &lt; 30% from baseline The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="83"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="41"/>
                <count group_id="O4" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="24"/>
                    <measurement group_id="O4" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adverse Events With a Grade of 3 and Above</title>
        <description>Participants reported at least 1 adverse event with a grade of 3 and above, regardless if the event is defined as serious per protocol or other.
Per protocol, not all grade 3 events are considered as serious events.</description>
        <time_frame>Up to 36 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Adverse Events With a Grade of 3 and Above</title>
          <description>Participants reported at least 1 adverse event with a grade of 3 and above, regardless if the event is defined as serious per protocol or other.
Per protocol, not all grade 3 events are considered as serious events.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="191"/>
                <count group_id="O2" value="184"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Putrescine by ODC Genotype</title>
        <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Baseline</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>ODC1 AA/GA</title>
            <description>Patients with AA or GA genotype</description>
          </group>
          <group group_id="O2">
            <title>ODC1 GG</title>
            <description>Patients with GG genotype</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Putrescine by ODC Genotype</title>
          <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>nmol/mg protein</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.47" lower_limit="0.01" upper_limit="4.60"/>
                    <measurement group_id="O2" value="0.56" lower_limit="0.01" upper_limit="5.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Spermidine by ODC Genotype</title>
        <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Baseline</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>ODC1 AA/GA</title>
            <description>Patients with AA or GA genotype</description>
          </group>
          <group group_id="O2">
            <title>ODC1 GG</title>
            <description>Patients with GG genotype</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Spermidine by ODC Genotype</title>
          <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>nmol/mg protein</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.99" lower_limit="0.76" upper_limit="9.18"/>
                    <measurement group_id="O2" value="2.17" lower_limit="1.05" upper_limit="8.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Spermine by ODC Genotype</title>
        <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Baseline</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>ODC1 AA/GA</title>
            <description>Patients with AA or GA genotype</description>
          </group>
          <group group_id="O2">
            <title>ODC1 GG</title>
            <description>Patients with GG genotype</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Spermine by ODC Genotype</title>
          <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>nmol/mg protein</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="101"/>
                <count group_id="O2" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.82" lower_limit="2.29" upper_limit="19.86"/>
                    <measurement group_id="O2" value="7.29" lower_limit="2.72" upper_limit="22.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>At the End of the Study - Putrescine Response by ODC Genotype</title>
        <description>Putrescine responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) â‰¥ the threshold. Putrescine non-responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>DFMO + Sulindac - GG</title>
            <description>Patients with GG genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>DFMO + Sulindac - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O3">
            <title>Placebo - GG</title>
            <description>Patients with GG genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O4">
            <title>Placebo - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>At the End of the Study - Putrescine Response by ODC Genotype</title>
          <description>Putrescine responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) â‰¥ the threshold. Putrescine non-responder was defined as (tissue putrescine value at baseline - tissue putrescine value at the end of the study)/(tissue putrescine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="31"/>
                    <measurement group_id="O4" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>At the End of the Study - Spermidine Response by ODC Genotype</title>
        <description>Spermidine responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) â‰¥ the threshold. Spermidine non-responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>DFMO + Sulindac - GG</title>
            <description>Patients with GG genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>DFMO + Sulindac - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O3">
            <title>Placebo - GG</title>
            <description>Patients with GG genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O4">
            <title>Placebo - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>At the End of the Study - Spermidine Response by ODC Genotype</title>
          <description>Spermidine responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) â‰¥ the threshold. Spermidine non-responder was defined as (tissue spermidine value at baseline - tissue spermidine value at the end of the study)/(tissue spermidine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>At the End of the Study - Spermine Response by ODC Genotype</title>
        <description>Spermine responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) â‰¥ the threshold. Spermine non-responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>DFMO + Sulindac - GG</title>
            <description>Patients with GG genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>DFMO + Sulindac - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O3">
            <title>Placebo - GG</title>
            <description>Patients with GG genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O4">
            <title>Placebo - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>At the End of the Study - Spermine Response by ODC Genotype</title>
          <description>Spermine responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) â‰¥ the threshold. Spermine non-responder was defined as (tissue spermine value at baseline - tissue spermine value at the end of the study)/(tissue spermine value at baseline) &lt; the threshold. The thresholds range from 0.25 to 0.45 with an increment of 0.5. The below data are shown for the threshold of 0.30.
ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="43"/>
                <count group_id="O4" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="18"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Responder</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Have Adenoma Recurrence in Each ODC1 Genotytpe by Treatment Group</title>
        <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
        <time_frame>Up to 36 months</time_frame>
        <population>The analysis cohort is based on the participants whose data are available and complete.</population>
        <group_list>
          <group group_id="O1">
            <title>DFMO + Sulindac - GG</title>
            <description>Patients with GG genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>DFMO + Sulindac - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O3">
            <title>Placebo - GG</title>
            <description>Patients with GG genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O4">
            <title>Placebo - AA/GA</title>
            <description>Patients with AA or GA genotype receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Have Adenoma Recurrence in Each ODC1 Genotytpe by Treatment Group</title>
          <description>ODC genotype is the genotype of single nucleotide polymorphisms (SNP) in the ornithine decarboxylase (ODC) promoter The analysis cohort is based on the participants whose data are available and complete.</description>
          <population>The analysis cohort is based on the participants whose data are available and complete.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="64"/>
                <count group_id="O2" value="42"/>
                <count group_id="O3" value="44"/>
                <count group_id="O4" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="22"/>
                    <measurement group_id="O4" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma: Apoptosis</title>
        <description>Apoptosis expression was assessed using cytoplasmic staining. The definitions for the category level for the Apoptosis are: 1. focal (less than 10% cells that are positively stained); 2. less than 50% cells are positively stained; 3. more than 50% cells are positively stained.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma: Apoptosis</title>
          <description>Apoptosis expression was assessed using cytoplasmic staining. The definitions for the category level for the Apoptosis are: 1. focal (less than 10% cells that are positively stained); 2. less than 50% cells are positively stained; 3. more than 50% cells are positively stained.</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>adenoma</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="38"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>adenoma</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A pattern equal to normal mucosa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.focal (&lt;10%)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.cyto less than 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.cyto more than 50%</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma - Ki-67</title>
        <description>Estimated mean percent of cells staining postivie for the Ki-67 based on the GEE approach with adjustment for covariates</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma - Ki-67</title>
          <description>Estimated mean percent of cells staining postivie for the Ki-67 based on the GEE approach with adjustment for covariates</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>percentage of cells that are positive</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.5" lower_limit="48.10" upper_limit="71.02"/>
                    <measurement group_id="O2" value="63.9" lower_limit="57.35" upper_limit="70.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma: CEA</title>
        <description>carcino-embryonic antigen (CEA) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma: CEA</title>
          <description>carcino-embryonic antigen (CEA) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>Adenoma</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Adenoma</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A pattern equal to normal mucosa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.&lt;50% of cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.50-90% of cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.&gt;90% of cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insufficient tissue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma: Sialyl-TN (B72.3)</title>
        <description>sialyl-Tn (B72.3) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma: Sialyl-TN (B72.3)</title>
          <description>sialyl-Tn (B72.3) is adenocarcinoma tissue marker that is expressed during adenoma formation.</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>Adenoma</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Adenoma</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>a pattern equal to normal mucosa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.&lt;10% of the cells in the adenoma showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.10-50% cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.&gt;50% cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insufficient tissue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma - p53</title>
        <description>Estimated mean percent of cells staining postivie for p53 based on GEE approach with adjument for covariates.
Tumor protein p53, also known as p53, cellular tumor antigen p53, phosphoprotein p53, or tumor suppressor p53, is a protein that in humans is encoded by the TP53 gene.</description>
        <time_frame>At the end of the study</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma - p53</title>
          <description>Estimated mean percent of cells staining postivie for p53 based on GEE approach with adjument for covariates.
Tumor protein p53, also known as p53, cellular tumor antigen p53, phosphoprotein p53, or tumor suppressor p53, is a protein that in humans is encoded by the TP53 gene.</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>percentage of cells that are positive</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.6" lower_limit="51.10" upper_limit="100.09"/>
                    <measurement group_id="O2" value="70.3" lower_limit="61.86" upper_limit="78.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Biomarker in Adenoma: Bcl-2</title>
        <description>bcl-2 is the anti-apoptotic protein BCL2</description>
        <time_frame>At the end of the study, up to 3 years</time_frame>
        <population>The analysis cohort is based on the participants whose data are available.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm I (Eflornithine and Sulindac)</title>
            <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
          <group group_id="O2">
            <title>Arm II (Placebo)</title>
            <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
          </group>
        </group_list>
        <measure>
          <title>Biomarker in Adenoma: Bcl-2</title>
          <description>bcl-2 is the anti-apoptotic protein BCL2</description>
          <population>The analysis cohort is based on the participants whose data are available.</population>
          <units>Adenoma</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Adenoma</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="66"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>A pattern equal to normal mucosa</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.&lt;10% of the cells in the adenoma showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.10-50% cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3.&gt;50% cells showed staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Insufficient tissue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The adverse event onset date occurred between the date of run-in and the date of off-study or date of follow-up (up to 3.5 years), when available.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm I (Eflornithine and Sulindac)</title>
          <description>Patients receive oral eflornithine (DFMO) and oral sulindac once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
eflornithine: Given orally
sulindac: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
        <group group_id="E2">
          <title>Arm II (Placebo)</title>
          <description>Patients receive oral double placebo once daily. In both arms, treatment continues for 36 months in the absence of unacceptable toxicity or the development of an invasive malignancy.
placebo: Given orally
laboratory biomarker analysis: Correlative studies</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="191"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE MYOCARDIAL INFARCTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANEURYSM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANGINA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>AORTIC STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHEST PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHEST PAIN AND PALPITATIONS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHEST PAIN X 3 WKS, R/O CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONGESTIVE HEART FAILURE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISEASE POST NON-ST ELEVATION MI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CORONARY ARTERY DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DISCHARGE SUMMARY 1/27/02 NEW ONSET ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEART DISEASE: A. CORONARY, B. NON-Q-WAVE INFARCTION, C. UNSTABLE ANGINA; CORONARY STENTING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFARCT MYOCARDIAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MYOCARDIAL INFARCTION/CHEST PAIN, ABNORMAL CARDIAC ENZYMES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN CHEST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>QUADRUPLE BYPASS SURGERY FOR CAD, UNSTABLE ANGINA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>R/O MI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STERNAL WOUND SURGICAL DEBRIDEMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>PARATHYROID DISORDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN MOST LIKELY SECONDARY TO ACUTE CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLITIS PSEUDOMEMBRANOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL BLEEDING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GASTROINTESTINAL BLEEDING SECONDARY TO ACUTE GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BLEED R/T DIVERTICULA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION; APPENDICITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INTESTINAL ILEUS STATUS POST CHOLECYSTECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OBSTRUCCTIVE JAUNDICE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PT. ADMITTED TO HOSPITAL FOR SPIGELIAN HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RENAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>CHOLECYSTITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GALLSTONES, PANCREATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>PANCREATITIS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SEPSIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION, HYPERGLYCEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UTI WITH SEPSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BROKEN RIGHT TIBIA UNDER KNEE D/T MVA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FX (L) ELBOW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION; FRACTURE OF LEFT ANKLE REQUIRING SURGICAL INTERVENTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>JOINT DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LUMBAR HERNIATED DISC AND LUMBAR RADICULOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MVA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PT WAS IN A MOTOR VEHICLE ACCIDENTâ€¦RECEIVED CONTUSIONS AND EXPERIENCED HEAD PAIN. PT WAS RESTRAINED.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT HIP PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT KNEE PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>S/P LEFT TOTAL HIP ARTHROSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>CARCINOMA PROSTATIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION FOR PANCREATIC NEOPLASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PANCREATIC CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>BENIGN POSITIONAL VERTIGO</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CEREBRAL INFARCTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CEREBROVASCULAR ACCIDENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PROBABLE RIGHT SUBCORTICAL INFARCT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SEIZURE ACTIVITY SECONDARY TO CEREBRAL ATROPHY OF RIGHT TEMPORAL LOBE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>BIPOLAR, EXACERBATED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DEPRESSION SUICIDAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MENTAL AND PHYSICAL BREAKDOWN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>BLADDER PROLAPSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION - OVERNIGHT OBSERVATION; LEFT KIDNEY BIOPSY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION UTI</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZED FOR ELECTIVE BLADDER SURGERY TO EVALUATE INCONTINENCE AND BIOPSY POSSIBLE TUMOR.</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KIDNEY CALCULUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NEPHROPATHY TOXIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>DUCTAL LEFT BREAST CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION VAGINAL BLEEDING TOTAL HYSTERECTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HOSPITALIZATION; BENIGN PROSTATIC HYPERTROPHY; ADMITTED FOR TRANSURETHRAL RESECTION OF THE PROSTATE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT URETERAL STONES, OBSTRUCTING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PROLAPSED CYSTOCELE; TOTAL HYSTERECTOMY WITH BILATERAL SALPINGO-OOPHORECTOMY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PROSTATE CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE SHORTNESS OF BREATH R/T CHF, IMPROVED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ACUTE SHORTNESS OF BREATH; CAD; UNSTABLE ANGINA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARRYTHMIA SINUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COPD EXACERBATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DYSPNEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MALIGNANT EPITHELOID NEOPLASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PNEUMONIA, SEPSIS SYNDROME, ACUTE RENAL FAILURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PNEUMONIA; POSSIBLE COPD EXACERBATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CELLULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CELLULITIS OF RIGHT LEG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT LEG CELLULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="173" subjects_at_risk="191"/>
                <counts group_id="E2" subjects_affected="154" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>A-FIB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL SMALL DOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CAD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* ALTERED LEFT VENTRICULAR DIASTOLIC FUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* ATRIAL FIBRILLATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* CONGESTIVE HEART FAILURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* DX -- POSSIBLE RETURN OF RENOVASCULAR HTN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* DX WITH CAD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* FLUID IN LUNGS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* HEART ATTACK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* HEART MURMUR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* HEART PALPITATIONS AND HYPERTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* LEFT BUNDLE BRANCH BLOCK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* MILD AORTIC SCLEROSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* MYOCARDIAL INFARCTION BY EKG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* NEAR FAINT EPISODES, DX HTN, ON DRUGS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* PALPITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* PALPITATIONS (PSVT)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* TACHYCARDIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* TACHYCARDIA EPISODES - INCREASED FREQUENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* UNSTABLE ANGINA, CHEST PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* VALVULAR HEART DISEASE - MILVAL VALVE REGURGITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* VASOVAGAL EPISODE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARDIAC* VASOVAGAL SYNCOPAL EPISODE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHEST PAIN RELATED TO 4/18 REPORT FOR HEART BURN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHEST PAIN WITH EXERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DX CHF</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED BLOOD PRESSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEART DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HIGH BLOOD PRESSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HTN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION /DIABETES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION MILD/MOD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION RETURNED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION SUSPECT OCULAR HYPERTENSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERTENSION UNCONTROLLED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE BP WITH RINGING IN EARS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OCC. CHEST TIGHTNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CLAUDICATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ELEVATED BLOOD PRESSURE/ SINGLE EVENT 9/00</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ELEVATED BLOOD PRESSURE; SINGLE 9/00</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HTN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HTN (R/T STRESS AND WEIGHT)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* CHEST</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* CHEST DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* CHEST; EXACERBATION OF PREVIOUS CONDITION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>BLEEDING* EAR CANALS, LEFT AND RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHANGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHANGE IN HEARING PER AUDIOGRAM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CHANGE IN SIGNIFICANT OTHER'S PERCEPTION OF HEARING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CN VIII</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EAR INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E2" events="7" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING &quot;CARBONIZATION SOUND&quot; - LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING /INNER EAR - &quot;STATIC NOISE&quot; LEFT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIO CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIO CHANGE SUBCLINICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIO SHOWS NO CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOGRAM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOGRAM CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOGRAM GRADE 1 HEARING CHANGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOGRAM ONLY</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETIC CHANGE, OFF STUDY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETRIC CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETRIC CHANGE BILATERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETRIC CHANGE LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETRIC CHANGE RIGHT EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDIOMETRIC CHANGE RIGHT EAR/ OVERALL NO SIGNIFICANT CHANGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING AUDITORY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE AUDIOGRAM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE NOTED ON AUDIO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE PER AUDIOGRAM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE-LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING CHANGE? PT NOT SURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DECREASE IN HEARING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DECREASE IN HEARING ABILITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DECREASE LEFT&gt;RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DECREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DECREASED RIGHT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING DIFFICULTY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARING CHANGE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARING LOSS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARING LOSS - SIGNIFICANT OTHER PERCEPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARING LOSS AUDIOMETRY ONLY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARNING LOSS/ SUBCLINICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HEARS PULSE IN LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING HUSBAND THINKS POSSIBLE HEARING CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING INNER EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS (SELF-PERCEPTION)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS + PAIN, LEFT NECK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS - SIGNIFICANT OTHER PERCEPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS IN LEFT EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING LOSS IN LEFT EAR, AUDIO DONE 11-30-00</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING MILD LOSS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING MUFFLED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING OTITIS MEDIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING OTOTOXICITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING OTOTOXICITY - AUDIOGRAM ONLY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING PLUGGED RIGHT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING POSSIBLE CHANGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING RIGHT EAR &quot;PLUGGED&quot; X2 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING RIGHT EAR PAIN/PLUG</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING RIGHT EAR PAIN/PLUG, EUSTACHIAN TUBE DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING SELF PERCEPTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING SELF PERCEPTION, DIFFICULTY WITH DISCRIMINATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING SLIGHT LOSS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARING TINNITUS (HAS GOTTEN SLIGHTLY WORSE OVER LAST 2 MONTHS)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT EAR INFECTION, RINGING WITH FULLNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DISCOMFORT LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EAR DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EAR PAIN AND PRESSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RIGHT EAR PRESSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTOTOXICITY* LEFT EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTOTOXICITY* R/EAR CLOGGED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTOTOXICITY* TINNITUS LEFT EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* EAR ACHE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* EAR PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT EAR SENSORAL HEARING LOSS -- AGE RELATED PER ENT MD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT SIDE ABOVE EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SIGNIFICANT OTHER PERCEPTION OF CHANGE IN HEARING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="191"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS - SLIGHT INTERFERRENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS CHRONIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS INCREASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS INCREASE, LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS INCREASED, LEFT EAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS LEFT EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS MAY HAVE INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS MILD INCREASE, AUDIO AT 6M</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS PRE-EXISTING - INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS VERY SLIGHT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS X1 EPISODE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINNITUS X4 EPISODES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>DIABETES NEW ONSET</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ENLARGED THYROID</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DECREASED THYROID FUNCTION, THIN HAIR, DECREASED TEMP, DRY SKIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DIABETES</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DIABETIC NEUROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DX OF DIABETES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ENDOCRINE -- HOT FLASHES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SMALL GOITER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>BIL. CATARACTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING IN EYE FROM THORN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CATARACT SURGERY RIGHT EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DRY EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FUZZY EYESIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMIANOPSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER CONJUNCTIVITIS, WITH OP EYE SURGERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BLEPHARITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CONJUNCTIVITIS (ALLERGIC)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DRY EYES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EPISCLERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* FLOATER D/T DIABETIC RETINOPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GLAUCOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GLAUCOMA INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ITCHY EYES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OCULAR - DRY MACULAR DEGENERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OCULAR - INCREASE INTRAOCULAR PRESSURE LEFT EYE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OCULAR/VISUAL MYOPIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* REDDENED EYES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RETINA EDEMA, POST OP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RETINAL TEAR LEFT EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RIGHT EYE BLURRINESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SUBORBITAL EDEMA, RIGHT EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* TEARY/WATERY EYES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PSEDOTUMOR EYE WILL F/U IN 6 MONTHS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SUBCONJUNCTIVAL HEMORRHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION BLURRED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION BLURRED RIGH EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION BLURRED WHEN READING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION BLURRING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION CATARACT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION CATARACT LEFT EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION CATARACTS, &quot;FLASHING LIGHT&quot;</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION DISTURBANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION FLASHING LIGHTS - BILATERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION FLOATERS - LEFT EYE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION FLOATERS, RIGHT EYE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION GLAUCOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION INCREASED INTRAOCULAR PRESSURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION LEFT EYE BLURRY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION MYOPIA, LACERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION RIGHT CATARACT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VISION SUB-CONJUNCTIVAL HEMMORHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN ABD CRAMPING AND BLOAT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN ABD. CRAMP AND CONSTIPATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN ABDOMINAL CRAMPING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN CRAMPING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN CRAMPS/ CONSTIPATION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN DIARRHEA X 1-2 DAILY, CRAMPING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN DIARRHEA X 3-4 DAILY, CRAMPING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN EPIGASTRIC PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LEFT SIDE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER ABDOMEN, INTERMITTENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN LOWER ABDOMINAL CRAMPING AFTER COLONOSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN OCCASIONAL ABD CRAMP WITH LOOSE STOOL WHEN NERVIOUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN STOMACH CRAMPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPSET STOMACH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLACK STOOLS (THINKS FROM MAALOX)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING GUMS DURING DENTAL VISIT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING RECTAL</sub_title>
                <counts group_id="E1" events="12" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING RECTAL 4 EPISODES BRBPR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING RECTAL BRB TOILET PAPER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING RECTAL HEMORRHOIDS</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* HEMATOCHEZIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* UPPER GI BLEED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING, RECTAL</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL /HEMORRHOID</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL BURGUNDY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL DIARRHEA, CRAMPING, BLACK STOOL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL DX: COLITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN STOOL OCCULT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD WITH BM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BOWEL MOVEMENT REGULARITY CONTINUES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONSTIPATION</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONSTIPATION CHRONIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONSTIPATION GETTING WORSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONSTIPATION INCONTINENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONSTIPATION R/T IMMODIUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CRAMPING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA</sub_title>
                <counts group_id="E1" events="49" subjects_affected="31" subjects_at_risk="191"/>
                <counts group_id="E2" events="47" subjects_affected="29" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA + ABDOMINAL CRAMPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA 2 EPISODES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA 3 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA AFTER COLONOSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA CONTINUED DIARRHEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA LOOSE STOOL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA LOOSER STOOL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA MILD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA OCCASIONAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIARRHEA X 1 RELATED TO FOOD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIVERTICULITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EARLY SATIETY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN 2-3 EPISODES PER WEEK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GAS PAINS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GAS X 1 PER MONTH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GASTRIC PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GERD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GERD (INCREASE SYMPTOMS)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN GERD, WORSENED, EST. START 1970</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN PAIN X 1</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EPIGASTRIC PAIN RIGHT SIDE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLATULENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GASTRIC REFLUX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GASTRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI ABDOMINAL BLOATING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BARRETT'S ESOPHAGUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BARRETT'S ESOPHAGUS/DYSPLASIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BLOATING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BLOATING / GAS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI BLOATING/FEELING OF INCOMPLETE EVACUATION, CONSISTENT WITH IBS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI CECUM BIOPSY: EROSIM WITH CHRONIC INFLAMMATION, NON-SPECIFIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI CONT. COLITIS SX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI CONT. ESOPHAGEAL IRRITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI ESOPHAGEAL FULLNESS RELATED TO GASTRO CIRCLAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN 1 - 2 EPISODES/WEEK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN 4 EPISODES WEEKLY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN 5-6 EPISODES/WEEK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN 5-6- EPISODES/WEEK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN X9 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI HEARTBURN, 1 EPISODE PER WEEK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI INCREASE IN GERD SYMPTOMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI INCREASED GERD SX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI INFLAMMATION COLITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI PEPTIC ULCER DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI STOMACH CRAMPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI UPPER GI PAIN/ACID REFLUX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI UPSET</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI UPSET STOMACH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI UPSET STOMACH X 2 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GI UPSET STOMACH X3 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GUM SORENESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>H. PYLORI +, STOMACH UPSET</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>H.PYLORI +, DX IBS - CONSTIPATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEARTBURN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMMORRHOID</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMORRHOIDS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMORRHOIDS FLARE-UP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE &quot;BURPING&quot;</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE FLATULENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE FREQ OF HEMORHOIDAL BLEEDING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE STOOL FREQUENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASE STOOLING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED BOWEL MOVEMENTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED FLATULENCE; ANAL INCONTINENCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED STOOLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INDIGESTION</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INDIGESTION DYSPEPSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INDIGESTION EPIGASTRIC PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INDIGESTION HEART BURN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LICHEN PLANUS MOUTH + TONGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LLQ ABDOMINAL PAIN WITH BM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOOSE STOOL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="191"/>
                <counts group_id="E2" events="16" subjects_affected="11" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA 5 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA AFTER COLONOSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA AND BELCHING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA NAUSEA/DIARRHEA/HEADACHE</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA POST SURGICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NAUSEA RELATED TO NEW MEDICINE GLUCOPHAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL HAD BUMP ON SURFACE OF TONGUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL SORE NEAR RIGHT INCISOR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL SORENESS, UPPER RIGHT GUM WHERE PREVIOUSLY BAD TOOTH REMOVED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL SORES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* BLISTER ROOF OF MOUTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* CANKER SORES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* CANKER SORES ON TONGUE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* CHAPPED LIPS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* COLD SORES, LIPS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DIFFICULTY SWALLOWING POSSIBLY DUE TO ROSACEA MEDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DISCOLORING OF TEETH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DISCOMFORT MOUTH, POST DENTAL WORK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DRY MOUTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DRY THROAT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DRY THROAT/MOUTH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DYSGEUSIA/TASTE DISTURBANCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* DYSPHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* EXACERBATION/ LICHEN PLANUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* GINGIVITIS FROM TEETH SCALING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* GUM PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* HYPERTROPHY, LUMP LEFT UPPER GUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* INCREASED SALIVA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* INTERMITTENT ORAL ULCERS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* LESION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* LESION ON LOWER LIP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* MOUTH DRYNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* MOUTH SORE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* MOUTH SORES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* PAIN - SOFT PALATE POST SURGICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* PAIN IN MOUTH POST PERIODONTAL SURGERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* PAIN RIGHT UPPER MOLAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* PRE-ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* SORE GUM - RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* SORE THROAT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* SORENESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* THROAT DRYNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* THROAT IRRITATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* TOOTH PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* ULCERS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ABDOMINAL BLOATING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ANAL FISTULA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ANAL FISTULA, SURG REPAIR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BLOATING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BLOATING, HX IBS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CRAMPING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DIFFICULTY SWALLOWING(DYSPHAGIA)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DYSPEPSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DYSPHAGIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ERODED ESOPHAGUS/GERD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ESOPHAGEAL SPASM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ESOPHAGEAL STRICTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ESOPHAGITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* FOOD POISONING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* FOOD POISONING: DIARRHEA. VOMITTING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GASTRITIS, DEHYDRATION, RESPIRATORY TRACT INFECTION, FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GERD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HARDER STOOLS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN</sub_title>
                <counts group_id="E1" events="15" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN 2X WEEKLY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN 3 TIMES A WEEK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN X 3 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN X5 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN, 3-4 EPISODES/WEEK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEARTBURN, INCREASE?</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEME + X3</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HT OF GASTRIC ULCERS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASED GAS WITH EATING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LOOSE SPHINCTER RECTURM-SEEPAGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LOOSE STOOL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MOUTH COLD SORE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ORAL SORENESS; ABCESS LOWER GUM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PERIANAL ABSCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PERIANAL SWELLING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RECTAL MOISTNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RECTAL URGENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RECTOCELE, VAGINAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RIGHT INGUINAL HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* STOMACH CRAMPING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* VERY LOOSE STOOL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN AND LOCAL SWELLING, UPPER LEFT MOLAR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* GAS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* PELVIC CRAMPING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RECTAL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* STOMACH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* TOOTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PROCTALGIA FUGAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PROTRUDING AND TENDER HEMORRHOIDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX ACID</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX ACID REFLUX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX ACID REFLUX 2-3 EPISODES/WK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX ACID REFLUX DAILY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX GASTRIC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX GERD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX GERD EPISODE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX GERD EPISODIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX GERD, INCREASED SEVERITY OF EPISODES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REFLUX INCREASED GERD, NUMBER OF EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT RENAL CYST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SLIGHT QUEEZY STOMACH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOMACH ACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOMACH FLU</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOMACH PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOMACH UPSET AND HEARTBURN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOMACH VIRUS (VIRAL GASTROECTERITIS)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* BLACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* CLEAR RECTAL DISCHARGE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* DISCOLORED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* HARD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* HIGHER FREQUENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* LOOSE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* LOOSE, 2-3 DAYS/WEEK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* LOOSER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* SOFT WITH ABDOMINAL CRAMPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STOOL* TARRY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TOOTH ABCESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TOOTH INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TOOTH INFECTION -&gt; ROOT CANAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UPPER HARD PALATE 1 CM ERYTHEMA W/ ULCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VIRAL GASTROENTERITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VOMITING AND NAUSEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VOMITING NAUSEA AND VOMITING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VOMITTING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>BIL LE EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BIL SWOLLEN FEET AND ANKLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* SHAVING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="191"/>
                <counts group_id="E2" events="11" subjects_affected="9" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS COLD X3-4</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS HEAD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS HEAD COLD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE</sub_title>
                <counts group_id="E1" events="34" subjects_affected="32" subjects_at_risk="191"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* ALLERGY FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* BILATERAL LEG FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* DIAPHORESIS AFTER MEALS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* MILD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* MILD DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* MUSCLE ACHES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* POSSIBLE VIRUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* R/T MUSCLE WEAKNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* RELATED TO MUSCLE WEAKNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* SYNCOPE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FATIGUE* WEAKNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER INTERMITTENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER SWEATS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER X 2DAYS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER X1</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU ACHY, NAUSEA, HEADACHE, COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU DIARRHEA N/V</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU FLU-LIKE SYMPTOMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU S/S</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU SYMPTOMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU X5 DAYS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOWGRADE FEVER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* + + PITTING BILATERAL ANKLE EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BAD COLD X 3 WKS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BILATERAL FOOT EDEMA R&gt;L</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BILATERAL LOWER EXTREMEITY EDEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CHILLS, JOINT PAIN, SKIN IS SENSITIVE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EDEMA LEFT EXTREMITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENERAL ACHES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENERAL BODY ACHES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASED STRESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LETHARGY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LOWER EXTREMITY EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LOWER EXTREMITY EDEMA - BILATERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SLEEPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* STRESS, INCREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SWELLING PERIPHERAL EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SWOLLEN ANKLES (PERIPHERAL EDEMA)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>OTHER* GALLSTONES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>OTHER* URTICARIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>BLEEDING* GUMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BROKEN TOOTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEVER BLISTERS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HERPES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED ORAL HERPES OUTBREAKS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* BLADDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* BLADDER INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* EAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* ESOPHAGITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* EUSTACHIAN TUBES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* FUNGAL FINGERNAIL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* FUNGAL INFECTION FINGERNAILS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* FUNGAL, LEFT MIDDLE FINGER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* INFECTED SCROTAL CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* INSECT BITE RIGHT ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* LEFT INDEX FINGER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* LEFT LOWER LEG AK SITE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* LEFT TESTICLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* MIDDLE EAR-BLOCKED EUSTACHIAN TUBE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* PNEUMONIA POSS &quot;SCAR&quot; ON CXR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* RIGHT BREAST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* RIGHT CALF BITE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* RIGHT MIDDLE FINGER NAIL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* SINUS</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* SINUS INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* SKIN FUNGAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* TOOTH</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* UPPER RESPIRATORY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* VAGINAL YEAST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* WOUND/INFECTION LEFT LE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INFECTION* YEAST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* YEAST INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HSV OUTBREAK</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>POSSIBLE FUNGAL INFECTION (SCALP)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TOE INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CUT SHIN = INFECTION (CELLULITIS)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FINGER LACERATION RIGHT HAND</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FOOT CONTUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CUTS TAKE LONGER TO HEAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LACERATION, ER VISIT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MECHANICAL FALL WITH LACERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PHLEBITIS LEFT FOREARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PHLEBITIS SUPERFICIAL LEFT FOREARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SPIDER BITE (LEG) SWELLING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SCORPION BITE RIGHT FOREARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SHIN LACERATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* STERNAL PAIN/BURNING SENSATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WOUND INFECT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WOUND* FACIAL CUT FROM FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WOUND* HEAD LACERATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WOUND* HEAD LACERATION ON SCALP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>5 LBS X 2 WKS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ABNORMAL X-RAY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DECREASE HGB 5% FROM BASELINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DECREASE IN HGB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DROP HGB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DROP IN HGB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELECT. BALANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED CREATININE BUN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED LIVER ENZYMES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED PSA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED TRIGLYCERIDE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED TRIGLYCERIDES 571</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ELEVATED TRIGLYCERIDES 779</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERGLICEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERGLYCEMIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HYPERKALEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED ALKPHOSPHATASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED ALT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED AST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED BILIRUBIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED CREATININE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED HEMOGLOBIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED LFTS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS 10 % HGB DROP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS 10% DROP HGB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS 10% DROP HGB WITH DYSMENORRHEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS 10% DROP IN HGB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ANEMIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ANEMIA - DROP IN HGB</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ANEMIA, MENSUS DISORDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ANEMIA: IRON DEFICIENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS B-12 DEFICIENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS BLOOD GLUCOSE ELEVATED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASE HGB GREATER THAN 10%</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASE IN HGB</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HBG 10% FROM BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HBG OF 10% BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HEMOGLOBIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HEMOGLOBIN &gt;10%</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HEMOGLOBIN NOT GREATER THAN 10% BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HEMOGLOBIN, REDRAW 12/4/01</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HGB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HGB GREATER THAN 10% BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HGB GREATER THAN 10% FROM BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HGB, 10% FROM BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED HGB: CHRONIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED NEUTROPHILS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DECREASED WBC</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS DROP IN HGB AND HEMATOCRIT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ELEVATED ALKALINE PHOSPHATASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ELEVATED BILIRUBIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ELEVATED PSA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS ENDOCRINE: ELEVATED BLOOD GLUCOSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HEMATURIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HGB DECREASE = 10%</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HGB DECREASE GREATER THAN 10%</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HGB DROP 10%</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HIGH ALT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HIGH AST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HIGH CHOLESTEROL LEVELS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HYPERCHOLESTEREMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HYPERKALEMIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS HYPERLIPIDEMIA</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS INCREASED ALKALINE PHOSPHATASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS INCREASED CHOLESTEROL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS INCREASED GLUCOSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS INCREASED HGB A1C</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW BLOOD SUGAR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW HEMOGLOBIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW HEMOGLOBIN AFTER SURGERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW HGB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW HGB - 10% FROM BASELINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOW HGB = 10%</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS LOWER WBC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS PROTEINURIA</sub_title>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS PSA ELEVATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS PSA LEVELS INCREASED (5 TO 8 TO 11)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS WHITE BLOOD CELL COUNT DECREASED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LABS WHITE BLOOD CELLS COUNT DOWN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOW BLOOD COUNT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* WHITE BLOOD CELL COUNT INCREASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SERUM GLUCOSE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>ANOREXIA</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="191"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANOREXIA DECREASED APPETITE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANOREXIA LOSS OF APPETITE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>APPETITE LOSS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEHYDRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS &gt;5%</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS AND DIARRHEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS DIETING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS DURING RUN-IN PERIOD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS INTENTIONAL</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS ON DIET REGIMEN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS PURPOSEFUL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEIGHT LOSS R/T ATKINS DIET (10 LBS)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ANKLE PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHIALGIA SHOULDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS ARTHRITIS FLARE UP - HANDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS BACK PAIN WORSENING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS BILATERAL KNEE PAIN R/T</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS EXACERBATION OF GOUT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS GOUT, RIGHT FOOT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS HAND PAIN (ARTHRITIS) OR (FIBROMYALGIA EPISODE)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS IN RIGHT KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS LEFT HAND JOINT PAIN R/T ARTHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS LEFT KNEE/ LEFT WRIST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS LEFT WRIST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS NECK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS OSTEO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS OSTEOARTHRITIS-LEFT KNEE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS OSTEOARTHRITIS-LEFT WRIST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS R THUMB JOINT PAIN R/T</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS RIGHT ELBOW</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS THUMB PAIN - ARTHRITIS BOTH HANDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ARTHRITIS TOE PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BACK PAIN (MOTRIN USE)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BACK PAIN, ON MOTRIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BACK STRAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BROKE BACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BROKEN ANKLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BROKEN TOE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DECREASED PERIPHERAL REFLEXES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EXACERBATION OF LEFT KNEE PAIN - ARTHRALGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FX RT GREAT TOE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GOUT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GROIN PULL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HAND PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HIP AREA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HIP BURSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HIP PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>JOINT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>JOINT PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KNEE PAIN</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT FLANK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT KNEE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEG CRAMPS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEG PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEG PAIN (RELATED TO HERNIATED DISC)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOW BONE DENSITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOWBACK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOWER BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOWERBACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCLE SPASMS IN BACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL ACHE ARM LEFT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL ACHINESS, TIGHTNESS - KNEES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL ANKLE INJURY, LEFT, R/T MISSTEP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BACK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BACK SPASM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BACK STRAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BILATERAL LOWER EXTREMITY FATIGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BILATERAL THIGH CRAMPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL BUMP INTERIOR TO LEFT ELBOW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CRAMPS THIGH RIGHT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL CRAMPS THIGHS BILATERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL FOOT PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL INCREASED BACK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL L2, L3 DISKS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL LEFT HIP PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL LEFT INGUINAL HERNIA, RECURRENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL MINOR BACK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL MUSCLE PAIN, RIGHT LEG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL MUSCLE SORENESS - R FOREMARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL MUSCLE WEAKNESS/SORENESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL NECK PAIN FROM FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL OLECRANON BURSITIS/CELLULITIS/ELBOW SWELLING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN - BILATERAL KNEE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL PAIN - RIGHT KNEE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL RIGHT KNEE SWELLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL RIGHT KNEE TORN MENISCUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL RIGHT ROTATOR CUFF, PAIN JOINT FUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL SCIATICA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL SHOULDER PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL SHOULDER PAIN CONTINUES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL SPRAINED ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL TAILBONE INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL THIGH CRAMPS BILATERAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL TORN ROTATOR CUFF, LEFT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL UNSTEADY GAIT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL VENTRAL HERNIA X 2</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NECK AND SHOULDER PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NECK PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NECK PAIN, INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OA PAIN (HIPS)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OLECRANON BURSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA LEFT ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA LEFT ELBOW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA LEFT SHOULDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA LEFT WRIST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA LOWER BACK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ARTHRALGIA NECK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BACK PAIN AND DIARRHEA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BACK STRAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BODY ACHES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BODY ACHES GENERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BONE SPUR/HEEL PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BROKEN RIGHT UPPER ARM AND RIGHT FOOT R/T FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BURSITIS - SHOULDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BURSITIS IN RIGHT SHOULDER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BURSITIS RIGHT SHOULDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BURSITIS-ELBOW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CARPAL TUNNEL SYNDROME BILATERAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* COCCYX INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEGENERATIVE JOINT DISEASE-RIGHT GREAT TOE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEGENERATIVE JOINT DISEASE; LOW BACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DISCOMFORT - RIGHT LEG</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DISCOMFORT LEFT KNEE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* KNEE STRAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LEFT ARM FRACTURE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LEFT FOOT ARCH BRUISE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MUCLE PULLED BACK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OSTEOPOROSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OSTEOPOROSIS-LEFT WRIST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PAIN-LEFT ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PLANTAR FASCIITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PLANTAR FASCIITIS LEFT FOOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SORE SHOULDER RELATED TO PAST BREAK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* STIFF FINGERS RIGHT. GOLF?</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* STRAIN LEFT ARM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* TENDON, BRUISED RIGHT ELBOW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN IN LOWER CALF</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* &quot;VAGUE PAIN&quot; WEAKNESS LEFT LEG</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* ALL OVER BODY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* ANKLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* ARTHRALAGIA LEFT HAND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E2" events="7" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK INCREASING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK INTERMITTENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK LOWER LEFT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK PAIN</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK PAIN WHILE EXERCISING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK X2 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BACK, MUSCLE SPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BILATERAL KNEE SORENESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BILATERAL SHOULDER PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BODY ACHES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* CERVICAL - NECK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* FINGER PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* FOOT PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* FOOT PAIN/SORE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* GENERAL MUSCLE/JOINT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* GREAT TOE RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* GREAT TOES PAINFUL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* GROIN PAIN/ PUBIC BONE WITH LONG SITTING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* HANDS JOINT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* HEADACHE SINUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* HIPS/BACK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* IN CHEST R/T FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* IN FRONT OF LEFT UPPER THIGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* JOINTS INCREASING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* JOINTS OF LEFT SIDE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* KNEE LIGAMENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* KNEE PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT ACHILLES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT ARM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT ARM W/TINGLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT FOOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT HAND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT HEEL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT HEEL BONE SPUR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT HIP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT LOWER EXTREMITY CLAUDICATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT NECK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT SHOULDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT THUMB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEG CRAMPS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LOW BACK</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LOWER BACK STIFFNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MILD BACK PAIN &quot;BURNING&quot;</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MUSCLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MUSCLE ACHES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MUSCLE STRAIN (PAIN) IN LOWER BACK (OCCASIONAL)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MUSCLE STRAIN/SPASM</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MVA - CHEST WALL PN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* MVA BACK PN/LEG PN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* NECK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* NECK &amp; BACK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* NECK &amp; UPPER CHEST PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* NECK, INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* PAIN IN LEFT LEG AND KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* PULLED MUSCLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT BACK PAIN, INJURY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT BUTTOCKS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT FLANK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT GREAT TOE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT HEEL</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT HEEL - PLANTAR FASCIITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT HIP AND KNEE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT KNEE - INCREASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT LEG PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT LOWER BACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT LOWER BACK AND LEFT KNEE PAIN</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT LOWER BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT SHOULDER</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT SHOULDER BLADE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT SHOULDER PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT SIDED PAIN AFTER EXERCISE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RLQ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RT LEG SECONDARY TO FALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RUQ PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SCIATICA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SHOULDERS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE KNEE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE LEFT BIG TOE - GOUT?</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE LEFT SHOULDER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE ON THUMB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE RT. KNEE, INCREASED PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SPRAINED ANKLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* STIFF NECK R/T HEAD BUMP IN BATH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* STIFFNESS &amp; PAIN IN WRIST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* TAILBONE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* UPPER RIGHT QUADRANT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN/MUSCULOSKELETAL/SOFT TISSUE; EXTREMITY - UPPER LEFT SHOULDER ROTATOR CUFF TEAR REAPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT ANKLE PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT ELBOW TENDONITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RIGHT TELBOW TENDONITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RT ELBOW FX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SEVERE BACK PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SHOULDER PAIN OLD INJURY FLAIR UP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SPRAINED ANKLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TENDONITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TMJ</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEAKNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEAKNESS LEFT HAND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEAKNESS LOWER EXTREMITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEAKNESS NEW - LEFT ARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WEAKNESS OVERALL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>CYST. DERMAL ON BACK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>EXCISED MASS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MASS FOUND ON CRX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MULTIPLE POLYPS (&lt;4MM) IN FLEX SIGMOIDOSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MULTIPLE POLYPS IN THE COLONOSCOPY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL GANGLION CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUSCULOSKELETAL MIDDLE FINGER CYST</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* 2 LUMPS IN GROIN AREA (SIZE 2 X 2 CM)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ADENOMA POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BIOPSY OF SKIN NEOPLASM, ABD. CYST AND THIGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BLADDER POLYP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BREAST LUMP (FNA NEG)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CYST IN GROIN WITH INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CYST ON BACK, DRAINED 10/10/00</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LEFT BREAST NODULE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LESION ON RIGHT THIGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LUMP IN RIGHT GROIN, LYMPHADENOPATHY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LUNG CANCER LEFT HILAR MASS SQUAMOUS CELL LYMPH NODE THORAX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PROSTATE CANCER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PROSTATIC ADENOCARCINOMA DX 7/01/03 BY BX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SHADOW IN LEFT LUNG, POSS. BENIGN TUMOR OR SCAR TISSUE. CT 3/10/04</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* UTERINE POLYP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>BALANCE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BALANCE BALANCE DISTURBANCE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BALANCE BALANCE DISTURBANCE DUE TO B12 MALABSORPTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BALANCE DISTANCE DISTURBANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BALANCE DISTURBANCE</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BELLS PALSY SIDE WEAKNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CARPAL TUNNEL SYNDROM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM HEADACHE RELATED TO CHOCOLATE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM INCREASE IN SEIZURES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM MEMORY LOSS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM MEMORY LOSS INCREASED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM MEMORY LOSS/FORGETFULNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CENTRAL NERVOUS SYSTEM MEMORY PROBLEMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="191"/>
                <counts group_id="E2" events="11" subjects_affected="8" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS AFT CERUMEN REMOVAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS FELL R/T LIGHT HEADED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS VERTIGO</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS/VERTIGO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIZZINESS/VERTIGO EPISODE LASTING LESS THAN 10 SEC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" events="22" subjects_affected="19" subjects_at_risk="191"/>
                <counts group_id="E2" events="26" subjects_affected="18" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE INTERMITTENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE NAUSEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE PAIN 5 EPISODES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE PRESSURE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE SIDE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE SINUS PAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE WITH NAUSEA AND VOMITING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE WITH NAUSEA AND VOMITTING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE WITH VISION INVOLVEMENT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEADACHE X1</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>INCREASED FREQUENCY OF DROPPING ITEMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MORE FREQUENT HEADACHES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NEUROLOGY - DIZZINESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NEUROPATHY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NEUROPATHY/SENSORY; TINGLING IN FINGERS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NUMBNESS/TINGLING OF RIGHT ARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OCCULAR MIGRAIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALTERED TASTE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALTERED TASTE CHOCOLATE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BILATERAL FOOT TINGLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DYSGEUSIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* FORGETFULNESS, LOSS OF TRAIN OF THOUGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASE IN TREMORS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LAPSES IN CONCENTRATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LIGHTHEADEDNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MILD PARESTHESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MILD PARESTHESIA, BILATERAL ARMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MODERATE PARESTHESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MODERATE PARESTHESIA IN RIGHT HAND</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* NERVOUS REACTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* NUMBNESS LEFT PINNA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PARESTHESIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PARESTHESIA GREAT TOE RIGHT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PARESTHESIA TOES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PARESTHESIA TOES LEFT FOOT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PARESTHESIA-LEFT ARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SYNCOPE X 1</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* TINGLING LEFT FOOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* TINGLING TONGUE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* UNSTEADY GAIT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RT. RING FINGER, RT PINKY NUMBNESS/TINGLING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PARKINSONS DISEASE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM*</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* ARMS TINGLE/GO NUMB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* HAND TREMBLINGS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* HAND TREMOR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* MILD PARESTHESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* MILD PARESTHESIA BOTH HANDS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* NEURO SCIATIC RIGHT LEG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* NEURO SCIATICA RIGHT LEG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* OLD INJURY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* PARESTHESIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* PARESTHESIA BILAT TINGLING IN SHOULDERS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* PARESTHESIA L/HAND NUMBNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* PARESTHESIA LEFT SHOULDER PINCHED NERVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* PERESTHESIA, FEET, INCREASED FROM BASELINE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* RIGHT FOOT TOE NUMBNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* RIGHT LEG NUMBNESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* SLIGHT TINGLING/NUMBNESS HANDS/WRIST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PERIPHERAL NERVOUS SYSTEM* SPINAL STENOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SLEEP APNEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SPINNING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINGLING BIL THIGH TO CALVES. OCCURS ~2X/MO</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>TINGLING IN FINGER TIPS (NEUROPATHYSENSORY)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VERTIGO</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VERTIGO POSITIONAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>VERTIGO SPINNING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ANXIETY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANXIETY AND DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANXIETY DEPRESSION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANXIETY INCREASED ANXIERTY AND BOREDOM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ANXIETY MOOD SWINGS, HOT FLASHES, ANXIETY</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DEPRESSION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DEPRESSION, MOM'S DEATH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FEELING HEATED AFTER TAKING MEDICATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>IRRITABILITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DECREASED LIBIDO</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEPRESSION - RECURRANCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DEPRESSIVE SX, RELATIONSHIP CONCERNS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* FEELS &quot;FUZZY&quot; IN HER HEAD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GRIEF/DEPRESSION FM. DEATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEAD GETS COLD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASE IN DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASED DEPRESSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INSOMNIA</sub_title>
                <counts group_id="E1" events="7" subjects_affected="3" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INSOMNIA - TROUBLE SLEEPING</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INSOMNIA INCREASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* IRRITABILITY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>BLEEDING* BLOOD IN THE URINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* BLOOD IN URINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* HEMATURIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* HEMATURIA - TRACE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* HEMORRHAGE HEMATURIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLOOD IN URINE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GENITOURINARY - URINATING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GENITOURINARY URINATING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>GLUCOSURIA</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMATARIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMATURIA-MICROSCOPIC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEMOGLOBINURIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KIDNEY PROBLEMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KIDNEY PROBLEMS/RENAL-OTHER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KIDNEY STONE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>KIDNEY STONES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LEFT KIDNEY STONE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENITOURINARY &quot;TWINGE&quot; RIGHT TESTICLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENITOURINARY BLADDER SPASMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENITOURINARY, LEFT TESTICLE TENDER/SWOLLEN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GENITOURINARY/ VAGINITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GU - URINARY FREQUENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* GU BLADDER SPASMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* IGA GLOMERULONEPHRITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCONTINENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASED URINARY URGENCY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASING INCONTINENCE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* KIDNEY STONES</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* TURP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* URGENCY TO URINATE WITH BURNING AT TIMES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* URINARY RETENTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* URINARY URGENCY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* URINATION PAIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN FROM KIDNEY STONES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* FLANK PAIN, KIDNEY STONES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>POSSIBLE RENAL CALCULUS (TOOK 1 VICODINE)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UTI</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UTI (BACK PN)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UTI UTI SX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>ABNORMAL PSA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* PENILE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* PROLONGED MENSTRUAL BLEEDING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* VAGINAL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* VAGINAL BLEED</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BPH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BX - BPH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ERECTILE DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ERECTILE DYSFUNTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DISCOMFORT POST PROSTATE BIOPSY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DX METRORRHAGIA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* DYSPLASIA PROSTATE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ENLARGED PROSTATE, PT PLACED ON PROZOSIN</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ERECTILE DYSFUNCTION, INCREASED SEVERITY OVER TIME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* IMPOTENCE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INCREASED PSA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* LEFT NIPPLE IRRITATED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* MENOPAUSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OCCASIONAL LOSS OF ERECTION DURING INTERCOURSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* VAGINAL ITCHING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* BREAST TENDERNESS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* LEFT TESTICLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* RIGHT BREAST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* TESTICLE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* TESTICULAR SORENESS &amp; SWELLING</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SEXUAL DYSFUNCTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ASTHMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ASTHMA FLARE-UP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* EPITAXIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BLEEDING* NOSE BLEED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BRONCHITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BRONCHOSPASM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS COUGH AND COLD SYMPTOMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS DX SINUS INFECTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS NASAL CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS POST NASAL DRIP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS SINUS DRAINAGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS SNIFFLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS SORE THROAT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD SYMPTOMS WITH COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD WITH URI SX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COLD/SINUS/EAR CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COUGH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COUGH*</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>COUGH* DRY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DX WITH EMPHYSEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DYSPNEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DYSPNEA (SHORTNESS OF BREATH)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DYSPNEA ON EXERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FLU-LIKE SYNDROME</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HEAD CONGESTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>MUCUS/COUGHING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>NOSEBLEED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ORAL* CONT. ESOPHAGEAL IRRITATION/SORE THROAT WITH DIFFICULTY SWALLOWING POSSIBLY DUE TO ROSACEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALLERGIC RHINITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALLERGIES</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALLERGY PET</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ALLERGY SYMPTOMS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BLOODY MUCOUS/ EXPECTORATED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* COPD EXACERBATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* EMPHYSEMA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HEMOPTISIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* INFECTION SINUS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* IRRITATED THROAT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* NASAL DISCHARGE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* POST NASAL DRIP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RUNNY NOSE</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SCRATCHY THROAT/SNIFFLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SINUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SINUS PROBLEM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SLEEP APNEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SNIFFLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SOB CHEST TIGHTNESS, POSSIBLE GERD SX</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SORE THROAT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* THROAT IRRITATION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* VOICE CHANGE - HOARSENESS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* SORE THROAT</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>POST NASAL DRIP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ALLERGIC RHINITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ALLERGIES/ASTHMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ASTHMA FLARE UP</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY ASTHMA FLARE-UP, WHEEZING, SOB</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY BRONCHIAL ASTHMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY BRONCHITIS</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY CHEST COLD SX, DX WITH PNEUMONIA RIGHT LUNG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY CHEST CRX, PNEUMONIA RIGHT LUNG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY CHOKING ON SALIVA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY CHRONIC RHINITIS CONTINUES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY COLD</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY COLD SYMPTOMS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY COLD SYMPTOMS: NASAL DRAINAGE, CONGESTION, COUGH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY COPD EXACERBATION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DIAPHRAGM DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DX WITH BRONCHIAL PNEUMONIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY DYSPNEA ON EXERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY INFECTION, BRONCHITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY PNEUMONIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY RHINITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SHORT OF BREATH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SHORTNESS OF BREATH</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SHORTNESS OF BREATH 2X</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SINUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SOB 6 EPISODES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SOB WITH EXERTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY SOB WITH HEAVY EXERCISE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY STUFFY NOSE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY UPPER RESPIRATORY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY UPPER, INFLUENZA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY UPPER, SINUS PROBLEM ALLERGY RELATED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RESPIRATORY URI</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RINORRHEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SEASONAL ALLERGIES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SHORTNESS OF BREATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION &amp; ALLERGIES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION ALLERGIES</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION HEAD CONGESTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION SINUS INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS CONGESTION SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS DISCOMFORT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS HEADACHE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUS INFECTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SINUSITIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SORE THROAT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SORE THROAT, COUGH, BODY ACHES, 103 TEMP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SORE THROAT, MUCUS/COUGH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>STREP THROAT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>UPPER RESPIRATORY INFECTION</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URI</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URI CHEST CONGESTION/COUGH/PHLEGM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URI COUGH AND SORE CHEST</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URI SINUS INFECTION/COUGH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>URI UPPER RESPIRATORY INFECTION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>WHEEZING W/ SWEATING SHORTNESS OF BREATH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>BASAL CELL SKIN LESION REMOVAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BASAL CELL TAKEN FROM FACE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>BRUISING LEFT HIP AREA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CELLULITIS - LEFT BREAST WOUND - NON INFECTIOUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>CELLULITIS LEF SIDE FACE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* 2 SPOTS ON SCALP</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* ACTINIC KERATOSES REMOVED X3</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* ACTINIC KERATOSIS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* ANAL SKIN TAG REMOVED</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BASAL CELL CARCINOMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BCC</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BLACK SPOT CHANGES ON SCALP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BOIL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BRUISES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* BRUISING INTERMITTENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* DERMATITIS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* DERMATITIS/ EXACERBATION THUMBS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* DISCOVERY AND REMOVAL OF BENIGN SKIN LESION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* DRY SKIN, FEET</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* EXTREME RASH ON TRUNK</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* FACIAL EDEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* FUNGAL INF.</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* IMPETIGO (NOSE)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* MELANOMA UPPER ARM MOLE SKIN EXCISION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* PERIANA PRURITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* PIGMENTATION SLOW TO FILL IN ON SCRAPE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* PRURITUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* R/O POSSIBLE SKIN CA SPOT SCHAGE COLOR AND SIZE, BX 2/12/04</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* RASH RIGHT ARM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* REMOVAL SKIN CA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* ROSACEA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* ROSACEA FLARE-UP</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN - BUMP, RED LEFT UPPER MOUTH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN - LESION RIGHT EAR ANTIHELIX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN LESION</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN LESION ABOVE FOREHEAD</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN LESIONS (REMOVED)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN RASH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN ROSACEA</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DERMATOLOGY* SKIN SENSITIVE TO SUN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>DIAPHORESIS ABDOMINAL DISCOMFORT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ERYTHORMATOUS PLAQUES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>FORHEAD LESION REMOVAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ITCHING AND RASH TO RECTUM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* 1 CM LESION ON RT. HAND</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ABCESS OF FINGER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ACTINIC KERATOSIS REMOVED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BASAL CELL CARCINOMA LEFT CLAVICLE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BASAL CELL CARCINOMA LEFT JAW</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BODY ODOR DIFFERENT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BOIL ON COCCYX</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CELLULITIS RIGHT KNEE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* COLD SORE (NOSE)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HOT AND SWEATY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* NAIL AVULSION, LEFT HALLUX NAIL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* NIGHT SWEATS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* OCCASIONAL BRUISING</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PRURITIUS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PRURITIUS LEGS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PRURITIUS, HIPS AND BELLY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PRURITUS, INTERMITTENT, BELLY, HIPS, LEGS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* PRURITUS, INTERMITTENT, HIPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RECTAL BOIL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RED LINE ON TOE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* RIGHT GREAT TOE WITH REDDISH SPOT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* SKIN LESION LEFT FOREARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ULCERATION, RT LOWER EXTREMITY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH ABDOMINAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH BODY AND EXTREMITIES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH BUMPS ON SKIN</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH EXACERBATION OF SEASONAL ITCHY RASH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH FACE</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH HANDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH ITCH</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH RIGHT CHEEK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH RIGHT FOOTECZEMA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH RIGHT FOREARM</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH RIGHT LEG</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH SHINGLES</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH SKIN RIGHT UPPER ARM</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RASH URTICARIA RIGHT BUTTOCK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>ROSACASE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SHINGLES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SKIN LESION REMOVED</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SKIN RASH</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SMALL OUTBREAKS OF PUSTULES UNDER NOSTRILS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SQUAMOUS CELL REMOVAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>HAND SURGERY - TRIGGER FINGER</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BRACHY THERAPY FOR PROSTATE CA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* BREAST BIOPSY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* CHEST X-RAY ABNORMAL, RIGHT UPPER LOBE LESION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* F/U 6MO CT</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* REMOVAL OF SHRAPNEL</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* ROOT CANAL X3</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* FROM SEED IMPLANT FOR PROSTATE CA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST - SURGICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST ORAL SURGERY</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST ROOT CANAL</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST SURGICAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>PAIN* POST TOOTH EXTRACTION</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>RELEASE OF CARPAL TUNNEL IN RIGHT HAND</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REMOVAL OF PINS FROM PRIOR BUNIONECTOMY RIGHT FOOT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>REMOVAL PRE-CAN SK.</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* CABG WOUNDS (CORONARY ARTERY BYPASS GRAFT)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* CHOLESYSTECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* DEVIATED SEPTUM &amp; UVULECTOMY</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* GUM SURGERY OUT PT</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* HERNIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* POSS BASAL CELL SKIN CANCER</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* PROSTATE RESTRUCTURING-ELECTIVE</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* RIGHT INGUINAL HERNIA REPAIR</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* ROTATOR CUFF REPAIR</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>SURGERY* TURP/HOSPITAL</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>HOT FLASHES</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LOWER LEG SWELLINGW</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>LYMPHADENITIS RIGT NECK</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="191"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="184"/>
              </event>
              <event>
                <sub_title>OTHER* HOT FLASHES, STOPPED HRT MEDS</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="191"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="184"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Frank Meyskens, Jr.</name_or_title>
      <organization>University of California, Irvine</organization>
      <phone>714-456-6310</phone>
      <email>flmeyske@uci.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

